Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
3.815
+0.125 (3.39%)
At close: Oct 1, 2026, 4:00 PM EDT
3.815
0.00 (0.00%)
After-hours: Oct 1, 2026, 4:10 PM EDT
Nasus Pharma Market Cap
Nasus Pharma has a market cap or net worth of $44.69 million as of October 1, 2026. Its market cap has decreased by -25.82% in one year.
Market Cap
44.69M
Enterprise Value
32.97M
1-Year Change
-25.82%
Ranking
Category
Stock Price
$3.82
ChartMarket Cap Chart
Since the IPO on August 14, 2025, Nasus Pharma's market cap has decreased from $72.08M to $44.69M, a decrease of -38.00%. That is a compound annual growth rate of -34.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 44.69M | -46.09% |
| Dec 31, 2025 | 82.90M | 15.01% |
| Aug 14, 2025 | 72.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 163.69B |
| Bristol-Myers Squibb Company | 128.41B |
| GSK plc | 98.21B |
| Sanofi | 97.03B |
| Biogen | 33.55B |
| Grifols | 6.44B |
| Organon & Co. | 3.61B |
| Amarin Corporation | 277.55M |